Despite significant progress in recent decades, global health issues—such as infectious diseases and lack of access to health care systems—still inflict immense suffering around the globe. This is especially true in the poorest parts of the world. If organizations in the public, private, and social sectors collaborate in new ways, they can make a bigger-than-ever impact on these challenges.
Epidemics and other global health threats affect individuals, families, and societies, and inflict costs that weaken the entire world economy. The numbers are staggering:
The CDC cites $12 billion is spent annually in direct costs related to malaria, with much more lost in economic growth.
The 2014 Ebola outbreak in West Africa spread fast—with more than 26,000 suspected or confirmed cases recorded by May 2015.
As organizations in every sector rally to achieve the UN’s Sustainable Development Goals, three new approaches can help them surmount these and other global health challenges:
These and other innovations could help make health care systems in lower income countries more efficient, effective, and adaptive by enabling them to leapfrog over long development timelines. By making these critical changes, emerging economies can thereby accomplish much more with much less.
Combating global health challenges will never be easy. But by forging new partnerships that leverage their diverse and complementary capabilities and embracing new technologies, organizations can come together to ease the widespread suffering caused by these health problems.
Vaccinating Nations: Country Planning for an Unprecedented Immunization Campaign
The need for a successful roll-out of COVID-19 vaccines cannot be overstated. What are the four key elements to consider when planning an end-to-end vaccination deployment?
Reimagining Global Health After the Coronavirus
What has worked, what can be improved, and what needs to be reimagined so that we are better prepared for the next pandemic and better able to improve health in the world’s poorest nations?
What happens after we develop a COVID-19 vaccine?
BCG Managing Director & Partner Johanna Benesty looks at barriers to "equitable access"—making sure COVID-19 therapeutics are available to all—and shares a creative approach to vaccine research and development.
Vaccines Aren’t the End of the Fight, but the End of the Beginning
Governments cannot let the most vulnerable be the least protected again. Countries, regions, and states can still get the rollout right through science, hard work, and vigilance.
Ensuring an Inclusive Recovery
COVID-19 is having a disproportionate impact on people who were already vulnerable: low income earners, racial minorities, and those without access to technology. We believe that public, private, and social sector leaders have a moral—and business—imperative to place inclusion at the heart of their response and recovery strategies.
Three Principles to Guide Africa’s COVID-19 Response
African governments must develop a response that is comprehensive, adaptive, and implemented effectively in order to take fast action in several areas.
Six Ways to Speed Progress on the Health SDGs
To meet the UN’s health-related Sustainable Development Goals, NGOs and low-income countries will have to do two to four times as much with every dollar that they currently spend.
BCG collaborates with the Bill & Melinda Gates Foundation to shift the world’s focus from controlling the disease to eradicating it.
Working closely with the World Health Organization, BCG supported the initial design of the Ebola response and developed a novel 30-60-90 day plan to get the epidemic under control.
BCG's Center for Health Care Value offers tailored solutions to organizations seeking to adopt value-based health care.
BCG's consultants and industry experts focusing on global health continue to partner with leading social organizations, corporations, nonprofits, and philanthropic bodies to arrive at solutions for epidemics and health care access. These are some of our experts on this topic.
Managing Director & Senior Partner, Paris and Nairobi
Managing Director & Partner
Managing Director & Senior Partner